1
|
Illes JD. Blood Pressure Change After Celery Juice Ingestion in a Hypertensive Elderly Male. J Chiropr Med 2022; 20:90-94. [PMID: 34987326 DOI: 10.1016/j.jcm.2021.04.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 01/28/2020] [Accepted: 04/05/2021] [Indexed: 11/17/2022] Open
Abstract
Objective The purpose of this study was to describe the response to the inclusion of celery juice in the diet of an elderly hypertensive patient with neck pain. Clinical Features A 74-year-old man presented with neck pain and a history of hypertension as diagnosed by his primary care provider. He had attempted different medications for his hypertension, but he reported that they gave him the side effect of chest discomfort. His initial physical examination blood pressure measurement was 150/80 mmHg. Intervention and Outcome Interventions included daily intake of celery juice over 6 months, which was approved by his medical doctor's nurse. For his neck pain, chiropractic grade mobilization to the restricted segments of the cervical spine was given over 14 in-office visits. There were no weight changes, addition of exercise, or other lifestyle changes reported. At the end of his care, his blood pressure measured 118/82 mmHg. Conclusion This elderly patient responded positively to the inclusion of celery juice and chiropractic care after 6 months.
Collapse
|
2
|
Rubin S, Boulestreau R, Couffinhal T, Combe C, Girerd X. [Impaired hypertension control in France: What the nephrologist needs to know]. Nephrol Ther 2020; 16:347-352. [PMID: 33069630 DOI: 10.1016/j.nephro.2020.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 09/29/2020] [Accepted: 10/01/2020] [Indexed: 01/13/2023]
Abstract
In France, 1 adult out of 3 is affected by hypertension and only 1 hypertensive out of 4 achieves blood pressure targets (<140/90mmHg). This proportion is significantly better in similar countries (e.g. England, Germany, the USA). Nephrologists are particularly concerned since although more than 90 % of Chronic Kidney Disease (CKD) stages 3 and 4 patients are hypertensive, the CKD-REIN cohort shows that in France more than 1 out of 2 patients with CKD remains with a blood pressure above 140/90mmHg. This report, based on the latest French studies and surveys, raises an important warning about the situation in France, discusses the main reasons for these results and offers some suggestions for improvement. Otherwise we risk a dramatic increase in the incidence of myocardial infarction, stroke, dependency and dementia in the coming years.
Collapse
Affiliation(s)
- Sébastien Rubin
- Service de néphrologie, transplantation rénale, dialyse et aphérèses, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France; Unité Inserm U1034, university Bordeaux, Bordeaux, France.
| | - Romain Boulestreau
- Service de cardiologie et hypertension artérielle, hôpital de Pau, 4, boulevard Hauterive, 64064 Pau, France
| | - Thierry Couffinhal
- Unité Inserm U1034, university Bordeaux, Bordeaux, France; Service de cardiologie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac cedex, France
| | - Christian Combe
- Service de néphrologie, transplantation rénale, dialyse et aphérèses, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France; Unité Inserm, U1026 BioTis, university Bordeaux, Bordeaux, France
| | - Xavier Girerd
- Fondation de recherche sur l'hypertension artérielle, 12, rue des Colonnes-du-Trône, 75012 Paris, France
| |
Collapse
|
3
|
Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 2018; 13:73. [PMID: 29728119 PMCID: PMC5935942 DOI: 10.1186/s13023-018-0815-5] [Citation(s) in RCA: 96] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 04/20/2018] [Indexed: 12/16/2022] Open
Abstract
Background Bradykinin-mediated angioedema (Bk-AE) can be life-threatening and requires specific targeted therapies. Knowledge of its epidemiology may help optimize its management. Methods We systematically searched the medical literature to identify abstracts of interest indexed between 1948 and March, 2016. We used published national survey data on the proportion of the population treated with angiotensin-converting enzyme inhibitors (ACEI) to derive estimates of the population prevalence of ACEI-AE in the USA, Germany and France. For hereditary angioedema (C1-INH-HAE) and C1-inhibitor related acquired angioedema (C1-INH-AAE), publications had to contain original epidemiologic data collection within a defined geographical area. Hereditary angioedema with normal C1-INH was not included in the analysis due to lack of clearly defined criteria. Results We identified 4 relevant publications on the prevalence of ACEI-AE, 6 on the prevalence of C1-INH-HAE, and 1 on the prevalence of C1-INH-AAE. The 1st year cumulative incidence of ACEI-AE was estimated to vary between 0.12 (population-based analyses) and 0.30 (meta-analyses of clinical trials) per 100 patient-years. The population prevalence of ACEI-AE was modeled to vary between 7 and 26 in 100,000. The prevalence of C1-INH-HAE was estimated to vary between 1.1 and 1.6 per 100,000. The prevalence of C1-INH-AAE was estimated to be 0.15 per 100,000 in one epidemiological investigation of AAE in Denmark. Conclusions Epidemiological evidence on Bk-AE is limited to North America and Europe. ACEI-AE is more common than C1-INH-HAE (~ 10:1), which is more common than C1-INH-AAE (~ 10:1). More studies are needed to comprehensively assess the epidemiological burden of Bk-AE.
Collapse
Affiliation(s)
- Emel Aygören-Pürsün
- Department for Children and Adolescents, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt, Germany.
| | - Markus Magerl
- Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Andreas Maetzel
- Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.,Kalvista Pharmaceuticals, Inc., Cambridge, MA, USA
| | - Marcus Maurer
- Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
4
|
Alami M, El Hattaoui M, Seqat M, Sadik J, Aouad A, Benghanem Gharbi M. Control of blood pressure and cardiovascular risk in Moroccan patients with newly diagnosed hypertension: a 3-month observational study in primary care. Ther Adv Cardiovasc Dis 2016; 11:49-56. [PMID: 27884949 DOI: 10.1177/1753944716677242] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Control of blood pressure and reduction of cardiovascular risk factors are mandatory in patients with hypertension. The aim of this study was to determine the proportion of patients with controlled hypertension and to describe the cardiovascular risk profile in hypertensive patients followed by general practitioners (GPs) in Morocco. METHODS This national, observational, multicentre, prospective, longitudinal study of patients with newly diagnosed hypertension was carried out between September 2011 and December 2011. The use of antihypertensive drugs was evaluated at inclusion and after 3 months of follow up. Uncontrolled hypertension was defined as systolic blood pressure (SBP) ⩾ 140 mmHg or diastolic blood pressure (DBP) ⩾ 90 mmHg at 3 months of follow up. The SCORE scale issued by the European Society of Cardiology (ESC) was used to assess overall cardiovascular risk and probability of experiencing a cardiovascular event within 10 years. RESULTS A total of 909 hypertensive patients were recruited (62.4% female). Mean age was 56.8 ± 10.6 years. More than half of the patients (53.0%) were between 40-60 years and more than one-third (34.1%) were obese [body mass index (BMI) ⩾ 30 kg/m2]. There were significantly more obese females than males ( p < 0.001). Over half of the patients (52.5%) had a high or extremely high cardiovascular risk. Abdominal obesity (measured as waist circumference) was the most common cardiovascular risk factor (61.7%) followed by age (40.5%), dyslipidaemia (36.3%) and diabetes (34.3%). Mean SBP decreased from 168.1 ± 14.8 to 138.3 ± 13.2 mmHg ( p < 0.001) and mean DBP decreased from 93.0 ± 10.5 to 81.0 ± 8.6 mmHg ( p < 0.001) after 3 months of treatment. Control of blood pressure was achieved in only 46.8% of patients. Poor compliance (17.1%) and a lack of treatment efficacy (16.9%) were the two main reasons for not achieving the blood pressure target. CONCLUSIONS More than half (53.2%) of the hypertensive patients in our study did not achieve adequate blood pressure control during the 3-month follow-up period and had a high cardiovascular risk. More effective management of hypertension is required in primary care.
Collapse
Affiliation(s)
- Mohamed Alami
- Private Medical Office, 264, Ghandi Street, Casablanca 20200, Morocco
| | - Mustapha El Hattaoui
- Department of Cardiology, PCIM Laboratory, FMPM, Cadi Ayyad University, Marrakesh, Morocco
| | - Mehdi Seqat
- Medical Affairs Department, Sanofi Maroc, Casablanca, Morocco
| | - Jamaa Sadik
- Medical Affairs Department, Sanofi Maroc, Casablanca, Morocco
| | | | - Mohammed Benghanem Gharbi
- Nephrology Department, Ibn Rushd University Hospital, Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco
| |
Collapse
|
5
|
Girerd X, Hanon O, Pannier B, Mourad JJ, Vaïsse B. [Determinants of controlled hypertension in patients treated with antihypertensive drugs in France: The French League Against Hypertension Survey (FLAHS 2015)]. Ann Cardiol Angeiol (Paris) 2016; 65:219-22. [PMID: 27199204 DOI: 10.1016/j.ancard.2016.04.019] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 04/20/2016] [Indexed: 11/15/2022]
Abstract
OBJECTIVE The FLASH 2015 survey sought the determinants of hypertension control in subjects treated with antihypertensive drugs in France. METHOD Sending self-administered questionnaire by mail to a representative sample of the population living in metropolitan France (MetaScope basis, TNS Sofres, France). Patients who declare taking antihypertensive drugs are considered treated hypertensives. A home blood pressure monitoring during 3 days was asked in subjects owing a blood pressure monitor and the average of 18 measurements was calculated. RESULTS A total of 6379 subjects aged 55 and older were included with 2814 (44.1%) treated with antihypertensive drugs. Home blood pressure was obtained from 1455 subjects including 882 (60.6%) treated. SBP/DBP are 129.3±13.5/75.5±9.0mmHg and are higher in treated subjects in each age category. BP<135/85 was observed in 55.4% and BP<140/90 in 71.7%. Determinants of BP control (<135/85) are the number of measurement for averaging (18 measures over 3 days vs 3 measurements on a morning; 55.4%/44.3%), age (55-64 years vs 80 years old; 57.6%/49.1%), gender (women vs men; 60.3%/50.1%), BMI (<25 vs >30; 63.1%/46.1%). In the 80 and older, a SBP<145 was observed in 74.7% of subjects. The control was 61% when considering an SBP/DBP<135/85 in 55-79 years and SBP<145 among 80 and older. CONCLUSION The control of hypertension evaluated by home blood pressure on a representative population living in metropolitan France is estimated at between 44.3% and 74.7% and several determinants influence the control of blood pressure like age, gender and BMI.
Collapse
Affiliation(s)
- X Girerd
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des colonnes-du-trône, 75012 Paris, France; Pôle cœur métabolisme, unité de prévention cardiovasculaire, hôpital de La Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
| | - O Hanon
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des colonnes-du-trône, 75012 Paris, France; Hôpital Broca service de gériatrie, université Paris Descartes, EA 4468, Assistance publique des hôpitaux de Paris, 54-56, rue Pascal, 75013 Paris, France
| | - B Pannier
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des colonnes-du-trône, 75012 Paris, France; Service de médecine, hôpital F.H. Manhès, 8, rue Roger-Clavier, 91712 Fleury-Mérogis, France
| | - J J Mourad
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des colonnes-du-trône, 75012 Paris, France; Unité médecine interne-HTA, hôpital Avicenne, 125, rue de Stalingrad, 93009 Bobigny, France
| | - B Vaïsse
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des colonnes-du-trône, 75012 Paris, France; Service de cardiologie unité hypertension, hôpital de la Timone, 264, rue Saint-Pierre, 13385 Marseille cedex 5, France
| |
Collapse
|
6
|
Moghadam MH, Imenshahidi M, Mohajeri SA. Antihypertensive effect of celery seed on rat blood pressure in chronic administration. J Med Food 2013; 16:558-63. [PMID: 23735001 DOI: 10.1089/jmf.2012.2664] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
This study investigated the effects of different celery (Apium graveolens) seed extracts on blood pressure (BP) in normotensive and deoxycorticosterone acetate-induced hypertensive rats. The hexanic, methanolic, and aqueous-ethanolic extracts were administered intraperitoneally and their effects on BP and heart rate (HR) were evaluated in comparison with spirnolactone as a diuretic and positive control. Also, the amount of n-butylphthalide (NBP), as an antihypertensive constituent, in each extract was determined by HPLC. The results indicated that all extracts decreased BP and increased the HR in hypertensive rats, but had no effect on normotensive rats. The data showed that administration of 300 mg/kg of hexanic, methanolic, and aqueous-ethanolic (20/80, v/v) extracts of the celery seed caused 38, 24, and 23 mmHg reduction in BP and 60, 25, and 27 beats per minute increase in the HR, respectively. Also, the HPLC analysis data revealed that the content of NBP in the hexanic extract was 3.7 and 4 times greater than methanolic and aqueous-ethanolic extracts. It can be concluded that celery seed extracts have antihypertensive properties, which appears to be attributable to the actions of its active hydrophobic constitutes such as NBP and can be considered as an antihypertensive agent in chronic treatment of elevated BP.
Collapse
Affiliation(s)
- Maryam Hassanpour Moghadam
- Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | | |
Collapse
|
7
|
Girerd X, Hanon O, Pannier B, Vaïsse B, Mourad JJ. [Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys]. Ann Cardiol Angeiol (Paris) 2013; 62:210-214. [PMID: 23759733 DOI: 10.1016/j.ancard.2013.04.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2013] [Accepted: 04/24/2013] [Indexed: 06/02/2023]
Abstract
OBJECTIVE To evaluate from studies conducted between 2002 and 2012, trends in the use of antihypertensive drugs in France. METHOD French League Against Hypertension Survey (FLAHS) were conducted in a representative sample of subjects aged 35 and over living in France. A list including the names for all antihypertensive drugs marketed at the time of each survey made it possible to detail drug therapies employed. Data analysis has taken the patient as a unity. The data obtained in 2002, 2007 and 2012 are subject to this analysis. RESULTS In 2012, 30% of the French population aged 35 and older was treated with antihypertensive drugs (11.4 million), while 24% were treated in 2002 (8.2 million). On average, prescription of antihypertensive included 1.4 ± 0.7 pills in 2002, 1.5 ± 0.8 in 2007 and 1.8 ± 0.9 in 2012, which corresponds to a pharmacological monotherapy prescribed in 47% of subjects in 2012, a different percentage than in 2007 (46%) and 2002 (56%). Over the period, the percentage of prescriptions of diuretics (41% to 42%) and ACE inhibitors (24% to 23%) and beta-blockers (35% to 36%) is stable, but they are increasing with ARBs (23% to 47%) and calcium antagonists (24% to 34%). The prescriptions of fixed-dose combinations were also increased (19% to 30%). In 2012, fixed-dose combinations included a diuretic (79%), an ARB (65%), an ACEI (23%) and a calcium antagonist (20%). Blood pressure control estimated with home blood pressure monitoring increases from 38% in 2002 to 50% in 2007 and 2012. CONCLUSION Changes in the use of antihypertensive drugs in France between 2002 and 2012 led to the prescription of antihypertensive treatment with associations in the majority. ARBs or ACEI are present on 70% of prescriptions with diuretics combined in 80%. Extensive use of fixed-dose combinations with diuretics and ARA2 characterizes this period in which it was observed an increase in blood pressure control in France.
Collapse
Affiliation(s)
- X Girerd
- Comité français de lutte contre l'hypertension artérielle (CFLHTA), 5, rue des Colonnes-Du-Trône, 75012 Paris, France.
| | | | | | | | | |
Collapse
|